BBK Worldwide Blog

HYBRID: A New Approach for Clinical Trial Recruitment & Engagement Success

Introducing a New Approach to Clinical Trial Recruitment & Engagement


Our hybrid approach to clinical trial recruitment and engagement provides sponsors with the flexibility and agility they need whether they are conducting a traditional site-based trial, hybrid trial, or decentralized trial. 

Read More

Topics: TrialCentralNet, Decentralized Clinical Trials, Decentralized Solutions, Hybrid Clinical Trials, Hybrid, TCN

Rob Laurens Goes One-on-One With Outsourcing-Pharma Discussing the Engagement Solution Center

Posted by Elizabeth Gargill


Earlier this week, BBK Principal Rob Laurens went one-on-one with Outsourcing-Pharma discussing the launch of BBK's Engagement Solution Center for decentralized and post-marketing clinical trials, which features concierge service delivery and a robust patient experience portal to ease the clinical trial journey.

In this in-depth interview, Rob addresses the importance and advantages of centralizing design, management, operations, and communications of patient support services. In addition, he provides insight into some of the conversations that led to the creation of the center. Click here to read the full article.

Read More

Topics: TrialCentralNet, Patient Engagement, Patient Centricity, Rob Laurens, Decentralized Trials, Outsourcing-Pharma, Inclusion, Engagement Solution Center, Concierge Services

BBK Worldwide Launches the Engagement Solution Center

Posted by BBK Worldwide


BBK Worldwide Launches the Engagement Solution Center for Decentralized and Post-Marketing Clinical Trial Success

Concierge Service Delivery and Robust Patient Experience Portal Ease Clinical Trial Journey

The COVID-19 pandemic has significantly accelerated the need to reshape research and development. Most specifically, it has led to demand for increased funding for decentralized and larger randomized clinical trials to inform clinical decisions and guide future research.

By launching the Engagement Solution Center, BBK Worldwide (BBK) is making patient-centric and inclusive trials an immediate and actionable reality for study sponsors.

Read More

Topics: TrialCentralNet, Rob Laurens, Decentralized Trials, Engagement Solution Center, Patient Centric, Post-Marketing

BBK Worldwide Recognized Among World's Most Disruptive Pharma Services Innovators

Posted by Elizabeth Gargill



BBK Worldwide Featured in Newly Published Innovations in Pharmaceutical Development


Guide Provides In-Depth Profiles of World’s Most Disruptive Pharma Services Innovators

BBK Worldwide has been recognized as a top innovator in Innovations in Pharmaceutical Development™. This newly published guide highlights the companies and thought leaders at the forefront of innovation in the pharmaceutical development space. 

Read More

Topics: TrialCentralNet, Patient Experience, Most Viewed, Clinical Trial Innovations, Innovations in Pharmaceutical Development

A Conversation About Clinical Trial Privacy Considerations and Advertising Efficacy - Part I

This is part one of a two-part series by Joan F. Bachenheimer, founding principal, and Matt Kibby, principal, technology and innovation, BBK Worldwide.

Read More

Topics: Patient Recruitment, TrialCentralNet, Technology, Metrics and Reporting, Site Selection

Real-Time Patient Recruitment Metrics for Clinical Trial Success

Posted by BBK Worldwide

It’s a no brainer that applied metrics are invaluable for more accurately projecting patient recruitment; however, many people assume that once a trial is underway, it’s no longer necessary to measure anything until all the study data are accumulated. That’s just not true. There is tremendous value  in the ongoing application of metrics, throughout the entire study cycle, so much so that we sometimes find it hard to imagine how anyone can conduct a successful study without metrics. But we’re not talking about numbers for numbers’ sake. It takes a great deal of expertise to know which measurements to take and how to interpret the findings.

Read More

Topics: TrialCentralNet, Metrics and Reporting

Technology and Innovation in Patient Recruitment for Clinical Trials

Posted by Matt Kibby

I tell my team that anything is possible within programming. Well. Maybe not anything. I mean – a computer can’t win the Olympic 100-meter dash for one! But when it comes to the programming world – there are always multiple ways of molding any innovative idea (new business requirements) into a working model (product).

Read More

Topics: Patient Recruitment, TrialCentralNet, mHealth, Technology

Patient Recruitment, Metaphorically Speaking

Posted by David Fleishman

Well, the first advertising run yielded some high results. And two weeks later, sites are still processing referrals at a high capacity. The preliminary analysis is in you’ve planned, strategized, and implemented. But then, you see a lack of screening and randomization activity at one particular site and think, “What is this site not doing?” Factors start to set in. Metrics make it clearer. Something has changed.

Read More

Topics: Patient Recruitment, TrialCentralNet, Technology

. . . Schminnovation

Posted by Matt Kibby

The ascent of the buzzword “innovation” in our industry conferences, articles, and blogs has been meteoric. Not sure about you, but for me it has become so mainstream and overused at this point that the word is now a popular cliché – something that is, in and of itself, indolent and predictable.

Read More

Topics: Patient Recruitment, Disruptive Innovation, TrialCentralNet, Technology

The TCN Backstory – Part Seven: Introducing the TCN Team: 15 Seconds of Fame

Posted by Jami Mohammed

In this post, our vlog author is Jami Mohammed, a TCN team specialist. Jami is one of the go-to guys on the team for questions and systems issues. However, in this silent vlog, Jami gives all the fame to his colleagues.

Andy Warhol once noted that, “In the future, everyone will be world-famous for 15 minutes.” Well that was 45 years ago, and the future has arrived. Trouble is, I really don’t think that anyone’s attention span lasts even remotely that long.

Read More

Topics: TrialCentralNet